BMP6 p.Pro95Ser
c.283C>T · rs199518216 · VCV1801214
Computational evidence
| Protein change | ||
| AlphaMissense | 0.473 | ambiguous |
|---|---|---|
| REVEL | 0.373 | indeterminate |
| SaProt | LLR -9.19 | tolerated |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.5 | GERP 0.68, phastCons 1 |
| Regional constraint | o/e 1.17 | unconstrained · MANE · 152 kb · p 7.1e-05 · regional, not allelic |
| Overall | ||
| CADD | 25.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 0.768% | 130 |
| Middle Easterngrpmax | 0.0667% | 1,500 |
| South Asian | 0.0652% | 1,535 |
| European (non-Finnish) | 0.0352% | 2,844 |
| Admixed American | 0.032% | 3,129 |
| Remaining individualsnot grpmax-eligible | 0.0193% | 5,171 |
| East Asian | 0.00672% | 14,878 |
| African / African-American | 0.00667% | 14,982 |
| Finnishnot grpmax-eligible | 0.00489% | 20,467 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BMP6
- Protein
- p.Pro95Ser
- Coding
- c.283C>T
- MANE Select
- NM_001718
- dbSNP
- rs199518216
- Type
- single nucleotide variant
- Location
- chr6:7727238 (GRCh38)
- Gene constraint
- LOEUF 0.523 · pLI 0.94 (gnomAD)
- Structure
- AlphaFold pLDDT 69.74 · 5 PDB
- Residue 95
- a UniProt-annotated variant site (in io; associated with disease susceptibility; some patients also carry a hfe variant; decreased function in positive regulation of smad protein signal transduction; results in partial activation of hepcidin expression; affects post-translational processing resulting in reduced amount of the mature form; results in impaired secretion); the 'disordered' region
Similar variants
- BMP6 p.Pro95Leu Uncertain significance ★ same residue
- BMP6 p.Leu209Pro Uncertain significance ★★ ⚠ same condition
- BMP6 p.Ile83Val Uncertain significance ★ ⚠ same condition
- BMP6 p.Pro199Ala Uncertain significance ★ ⚠ same condition
- BMP6 p.Arg257His Likely benign ★ same condition
- BMP6 p.Gln113Glu Benign ★ same condition
- BMP6 p.Leu96Pro Likely benign ★ same condition
- BMP6 p.Ser160= Benign/Likely benign ★★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bmp6-p-pro95ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown